208 related articles for article (PubMed ID: 19995841)
1. Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials.
Laron M; Cheng H; Zhang B; Schiffman JS; Tang RA; Frishman LJ
Mult Scler; 2009 Dec; 15(12):1431-41. PubMed ID: 19995841
[TBL] [Abstract][Full Text] [Related]
2. Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.
Laron M; Cheng H; Zhang B; Schiffman JS; Tang RA; Frishman LJ
Mult Scler; 2010 Apr; 16(4):412-26. PubMed ID: 20207786
[TBL] [Abstract][Full Text] [Related]
3. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
Fraser CL; Klistorner A; Graham SL; Garrick R; Billson FA; Grigg JR
Ophthalmology; 2006 Feb; 113(2):323.e1-323.e2. PubMed ID: 16406544
[TBL] [Abstract][Full Text] [Related]
4. A comparison of multifocal and conventional visual evoked potential techniques in patients with optic neuritis/multiple sclerosis.
Grover LK; Hood DC; Ghadiali Q; Grippo TM; Wenick AS; Greenstein VC; Behrens MM; Odel JG
Doc Ophthalmol; 2008 Sep; 117(2):121-8. PubMed ID: 18204943
[TBL] [Abstract][Full Text] [Related]
5. Latency of Multifocal Visual Evoked Potential in Multiple Sclerosis: A Visual Pathway Biomarker for Clinical Trials of Remyelinating Therapies.
Klistorner A; Triplett JD; Barnett MH; Yiannikas C; Barton J; Parratt J; You Y; Graham SL
J Clin Neurophysiol; 2021 May; 38(3):186-191. PubMed ID: 33235179
[TBL] [Abstract][Full Text] [Related]
6. Multifocal VEP assessment of optic neuritis evolution.
Alshowaeir D; Yannikas C; Garrick R; Van Der Walt A; Graham SL; Fraser C; Klistorner A
Clin Neurophysiol; 2015 Aug; 126(8):1617-23. PubMed ID: 25481337
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of visual evoked potentials and spectral domain optical coherence tomography in early relapsing remitting multiple sclerosis.
Behbehani R; Ahmed S; Al-Hashel J; Rousseff RT; Alroughani R
Mult Scler Relat Disord; 2017 Feb; 12():15-19. PubMed ID: 28283099
[TBL] [Abstract][Full Text] [Related]
8. Stereoacuity testing discloses abnormalities in multiple sclerosis without optic neuritis.
Sobaci G; Demirkaya S; Gundogan FC; Mutlu FM
J Neuroophthalmol; 2009 Sep; 29(3):197-202. PubMed ID: 19726941
[TBL] [Abstract][Full Text] [Related]
9. Empirical mode decomposition processing to improve multifocal-visual-evoked-potential signal analysis in multiple sclerosis.
de Santiago L; Sánchez-Morla E; Blanco R; Miguel JM; Amo C; Ortiz Del Castillo M; López A; Boquete L
PLoS One; 2018; 13(4):e0194964. PubMed ID: 29677200
[TBL] [Abstract][Full Text] [Related]
10. Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history.
Taş A; Cakir Gundogan F; Akgun H; Erdem U; Sobaci G
Med Glas (Zenica); 2013 Feb; 10(1):99-105. PubMed ID: 23348170
[TBL] [Abstract][Full Text] [Related]
11. Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential.
Klistorner A; Garrick R; Barnett MH; Graham SL; Arvind H; Sriram P; Yiannikas C
Neurology; 2013 Jan; 80(3):242-5. PubMed ID: 23269599
[TBL] [Abstract][Full Text] [Related]
12. Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.
Gundogan FC; Tas A; Altun S; Oz O; Erdem U; Sobaci G
Indian J Ophthalmol; 2013 Mar; 61(3):100-3. PubMed ID: 23514643
[TBL] [Abstract][Full Text] [Related]
13. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis.
Alshuaib WB
Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):243-52. PubMed ID: 10907603
[TBL] [Abstract][Full Text] [Related]
14. Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
Kiiski HS; Ní Riada S; Lalor EC; Gonçalves NR; Nolan H; Whelan R; Lonergan R; Kelly S; O'Brien MC; Kinsella K; Bramham J; Burke T; Ó Donnchadha S; Hutchinson M; Tubridy N; Reilly RB
PLoS One; 2016; 11(1):e0146084. PubMed ID: 26726800
[TBL] [Abstract][Full Text] [Related]
15. Determining abnormal interocular latencies of multifocal visual evoked potentials.
Hood DC; Zhang X; Rodarte C; Yang EB; Ohri N; Fortune B; Johnson CA
Doc Ophthalmol; 2004 Sep; 109(2):177-87. PubMed ID: 15881264
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of multifocal visual evoked potential and traditional visual evoked potential in normal and multiple sclerosis eyes.
Narayanan D; Cheng H; Tang RA; Frishman LJ
Doc Ophthalmol; 2015 Feb; 130(1):31-41. PubMed ID: 25351235
[TBL] [Abstract][Full Text] [Related]
17. Sparse multifocal stimuli for the detection of multiple sclerosis.
Ruseckaite R; Maddess T; Danta G; Lueck CJ; James AC
Ann Neurol; 2005 Jun; 57(6):904-13. PubMed ID: 15929047
[TBL] [Abstract][Full Text] [Related]
18. Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis.
Fraser C; Klistorner A; Graham S; Garrick R; Billson F; Grigg J
Arch Neurol; 2006 Jun; 63(6):847-50. PubMed ID: 16769865
[TBL] [Abstract][Full Text] [Related]
19. Visual evoked potentials in multiple sclerosis patients treated with interferon beta-1a.
Liscić RM; Brecelj J
Croat Med J; 2004 Jun; 45(3):323-7. PubMed ID: 15185427
[TBL] [Abstract][Full Text] [Related]
20. Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.
Blanco R; Pérez-Rico C; Puertas-Muñoz I; Ayuso-Peralta L; Boquete L; Arévalo-Serrano J
Mult Scler; 2014 Feb; 20(2):183-91. PubMed ID: 23828868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
